Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Taguchi

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Cellular and Molecular Life Sciences : CMLS|September 12, 2002
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic diseaseL G Bucciarelli, T Wendt, L Rong, et al.
Bone|May 17, 2008
Observer performance in diagnosing osteoporosis by dental panoramic radiographs: results from the osteoporosis screening project in dentistry (OSPD)A Taguchi, A Asano, M Ohtsuka, et al.
Journal of the American College of Cardiology|November 6, 2001
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndromeY Tanabe, M Inagaki, T Kurita, et al.
European Heart Journal|June 19, 2002
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndromeT Noda, H Takaki, T Kurita, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null miceT Kislinger, N Tanji, T Wendt, et al.
Cell|July 10, 1999
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptidesM A Hofmann, S Drury, C Fu, et al.
Therapeutic Advances in Medical Oncology|December 14, 2018
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)Sara Hurvitz, Rashi Singh, Brad Adams, et al.
Nature|June 1, 2000
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastasesA Taguchi, D C Blood, G del Toro, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Cellular and Molecular Life Sciences : CMLS|September 12, 2002
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic diseaseL G Bucciarelli, T Wendt, L Rong, et al.
Bone|May 17, 2008
Observer performance in diagnosing osteoporosis by dental panoramic radiographs: results from the osteoporosis screening project in dentistry (OSPD)A Taguchi, A Asano, M Ohtsuka, et al.
Journal of the American College of Cardiology|November 6, 2001
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndromeY Tanabe, M Inagaki, T Kurita, et al.
European Heart Journal|June 19, 2002
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndromeT Noda, H Takaki, T Kurita, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null miceT Kislinger, N Tanji, T Wendt, et al.
Cell|July 10, 1999
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptidesM A Hofmann, S Drury, C Fu, et al.
Therapeutic Advances in Medical Oncology|December 14, 2018
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)Sara Hurvitz, Rashi Singh, Brad Adams, et al.
Nature|June 1, 2000
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastasesA Taguchi, D C Blood, G del Toro, et al.
Pageof 16